#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal cancer metastatic Obesity Neonatal alloimmune thrombocytopenia Hereditary hypophosphataemic rickets Squamous cell carcinoma of the vulva Retinal artery occlusion Splenic marginal zone lymphoma Leukoencephalopathy Epstein-Barr virus infection Pulmonary tuberculosis Adenocarcinoma gastric Essential thrombocythaemia Adenovirus infection Acute promyelocytic leukaemia Transient ischaemic attack More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Trials in Disease Urea cycle disorder SAPHO syndrome – Life with Disease Mantle cell lymphoma refractory – Treatment Glomerulonephritis membranoproliferative – Treatment Nephroblastoma Factor VIII deficiency Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Mantle cell lymphoma stage III – Basic Information Bronchopulmonary dysplasia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydrocortisone Hemisuccinate Skin Autograft Levothyroxine Itepekimab Amiodarone Hydrochloride Ag-946 Phosphate Daunorubicin Hydrochloride Bleomycin Methylphenidate Hydrochloride Ceftolozane Estriol Posdinemab HYPOCHLOROUS ACID D,L-Lysine Acetylsalicylate Namodenoson Ioflupane (123I) Triptorelin Pamoate Bbp-398 HRS 9531 Peboctocogene Camaparvovec More therapies…

    Learn about Your Condition

    Atopic keratoconjunctivitis Ovarian cancer stage III Brain cancer metastatic Nicotine dependence Bile acid synthesis disorder Red blood cell abnormality Hairy cell leukaemia Metastatic gastric cancer Pancreatic carcinoma stage IV Sexual dysfunction Intracranial calcification Hypoxia Antithrombin III deficiency Meniere's disease Phaeochromocytoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Mbal Za Zhensko Zdrave Nadezhda OOD

Mbal Za Zhensko Zdrave Nadezhda OOD

Blaga Vest Street 3, Sofia, 1330, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • For-6219
    • Naproxen Sodium
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Avelumab
    Bulgaria France Hungary Italy Poland Romania +1

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Abemaciclib
    • Letrozole
    Belgium Bulgaria Czechia Denmark Finland France +10
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!